Clinical trial
Gene Therapy in Treating Patients With Ovarian Cancer
NCT00003588 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003588 |
|---|---|
| Title | Gene Therapy in Treating Patients With Ovarian Cancer |
| Official title | A Phase I Study of Ad-p53 (NSC# 683550) for Patients With Platinum- and Paclitaxel-Resistant Epithelial Ovarian Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological, Procedure |
| Interventions | Ad5CMV-p53 gene, laparoscopic surgery |
| Enrollment | 30 |
| Start date | Sep 1, 1998 |
| Primary completion | Mar 1, 2002 |
| First posted | Aug 26, 2004 |
| Last update posted | Feb 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: